Company / Assets per Share
Terns Pharmaceuticals, Inc. Assets per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$4.58
FY2024
5-year range
$3.77 / $323.64
FY2020-FY2024
Trend
+21.5%
vs FY2023
Sector context
#154 of 208
Health Care
What the data says
At $4.58, Terns Pharmaceuticals, Inc.'s assets per share ranks #154 of 208 in the Health Care sector. Assets per Share has fluctuated over the past 5 years, ranging from $3.77 in FY2023 to $323.64 in FY2020.
Based on SEC 10-K filings.
4.58 in FY2024 with a 3-year CAGR of -14.8%.
Declined from $7.97 to $4.58 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -14.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#154 of 208 in Health CareTop 74% of 208This company $4.58 Sector average $377.57
▼
-98.8% below sector average
Key checks
Key Insights
- In FY2024, assets per share increased 21.5% year-over-year.
- Ranks #154 out of 208 companies in the Health Care sector.
- Peak assets per share was recorded in FY2020.
- Lowest assets per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 7.86 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $4.58 | +21.5% |
| FY2023 | $3.77 | -52.7% |
| FY2022 | $7.97 | +7.6% |
| FY2021 | $7.40 | -97.7% |
| FY2020 | $323.64 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026